4.2 Article

Role of defensins in the pathogenesis of chronic lung allograft rejection

期刊

HUMAN IMMUNOLOGY
卷 75, 期 4, 页码 370-377

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.humimm.2013.12.014

关键词

-

资金

  1. NIH [HL056643, HL092514]
  2. ISHLT Research Fellowship

向作者/读者索取更多资源

Chronic rejection predominantly manifested as bronchiolitis obliterans syndrome (BUS), still remains a major problem affecting long-term outcomes in human lung transplantation (LTx). Donor specific antibodies (DSA) and infiltration of neutrophils in the graft have been associated with the development of BUS. This study determines the role of defensins, produced by neutrophils, and its interaction with alpha- 1-antitrypsin (AAT) towards induction of airway inflammation and fibrosis which are characteristic hallmarks of BUS. Bronchoalveolar lavage (BAL) and serum from LTx recipients, BOS+ (n = 28), BOS- (n = 26) and normal healthy controls (n = 24) were analyzed. Our results show that BOS+ LTx recipients had higher alpha-defensins (HNP1-3) and beta-defensin2 HBD2 concentration in BAL and serum compared to BOS-DSA-recipients and normal controls (p = 0.03). BOS+ patients had significantly lower serum AAT along with higher circulating concentration of HNP-AAT complexes in BAL (p = 0.05). Stimulation of primary small airway epithelial cells (SAECs) with HNPs induced expression of HBD2, adhesion molecules (ICAM and VCAM), cytokines (IL-6, IL-1 beta, IL-13, IL-8 and MCP-1) and growth-factor (VEGF and EGF). In contrast, anti-inflammatory cytokine, IL-10 expression decreased 2-fold (p = 0.002). HNPs mediated SAEC activation was completely abrogated by PAT. In conclusion, our results demonstrates that neutrophil secretory product, a-defensins, stimulate p-defensin production by SAECs causing upregulation of pro-inflammatory and pro-fibrotic signaling molecules. Hence, chronic stimulation of airway epithelial cells by defensins can lead to inflammation and fibrosis the central events in the development of BUS following LTx. (C) 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据